Hartford Funds Management Co LLC Has $2.78 Million Position in HCA Healthcare, Inc. $HCA

Hartford Funds Management Co LLC lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 32.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 5,874 shares of the company’s stock after buying an additional 1,434 shares during the quarter. HCA Healthcare makes up about 0.2% of Hartford Funds Management Co LLC’s holdings, making the stock its 19th largest holding. Hartford Funds Management Co LLC’s holdings in HCA Healthcare were worth $2,782,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. State Street Corp increased its position in shares of HCA Healthcare by 1.0% during the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after acquiring an additional 76,039 shares in the last quarter. Capital World Investors boosted its stake in HCA Healthcare by 0.8% in the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after purchasing an additional 40,086 shares during the period. Geode Capital Management LLC raised its stake in shares of HCA Healthcare by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after purchasing an additional 13,565 shares during the period. Norges Bank acquired a new position in shares of HCA Healthcare during the fourth quarter worth about $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after acquiring an additional 245,887 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 3.9%

Shares of NYSE:HCA opened at $390.81 on Tuesday. The stock has a market cap of $86.70 billion, a PE ratio of 13.44, a P/E/G ratio of 1.29 and a beta of 1.12. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The business has a 50 day moving average of $396.68 and a 200-day moving average of $459.73.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the business posted $6.45 earnings per share. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.73%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on HCA. Oppenheimer lowered their price objective on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. KeyCorp cut their price target on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Royal Bank Of Canada decreased their price objective on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Truist Financial set a $413.00 price target on HCA Healthcare in a research report on Thursday, June 4th. Finally, Leerink Partners lowered their price target on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Fourteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $496.77.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.